Tofizopam: a benzodiazepine derivative without sedative effect

Area of Science:

• Pharmacology
• Clinical Medicine
• Neuroscience

Background:

• Premedication is often used to manage patient anxiety and sedation before surgical procedures.
• The pharmacological effects of tofizopam, particularly its metabolite's action, require further elucidation.
• Understanding drug response variability is crucial for optimizing therapeutic outcomes.

Purpose of the Study:

• To evaluate the efficacy of tofizopam as a single oral dose premedication for minor surgery.
• To assess the effects of repeated oral tofizopam administration before gynecologic operations.
• To investigate the potential role of tofizopam metabolites in observed drug effects.

Main Methods:

• Single-blind randomized study comparing tofizopam (100 mg orally) with placebo and no premedication.
• Double-blind randomized study comparing tofizopam (100 mg orally, three times daily) with placebo.
• Measurement of subjective sedative effects, and patient apprehension and excitement levels.

Main Results:

• Single tofizopam dose did not differ significantly from placebo in sedative effects or measured parameters.
• Repeated tofizopam doses exhibited a stimulant action, significantly reducing patient apprehension and excitement compared to placebo.
• Wide interindividual variation in drug response was observed, suggesting potential metabolite involvement.

Conclusions:

• A single dose of tofizopam may not provide significant anxiolytic or sedative benefits over placebo.
• Repeated oral tofizopam administration appears to have a beneficial effect on reducing pre-operative apprehension and excitement.
• The findings suggest an active metabolite of tofizopam, requiring accumulation in the central nervous system for a discernible effect.